This Forum brings together forward-thinking investors and a hand-selected group of high-potential startups for focused, insight-driven presentations.
Each company delivers a 5-minute presentation with Q&A, designed to surface meaningful discussion, validate opportunity, and accelerate engagement.
The program also features updates from select alumni companies, offering a clear view into post-Forum progress, milestones achieved, and future direction.
Where innovation meets traction—and relationships turn into outcomes.
Neurava is a strategic and venture backed MedTech company developing a first of its kind AI-powered wearable platform to detect and alert for convulsive seizures as well as any induced cardio-respiratory dysfunctions, to stratify high risk patients and help prevent SUDEP. The company will be FDA cleared and on the market in 2026 with an experienced commercial team and board, including the former chairman of LivaNova.
ReEngage Therapeutics, Inc., is a clinical stage oncology company focused on developing novel treatments for longevity-related diseases, including neurodegeneration and cancer. The company is developing a de-risked molecule, MTB-9655, to treat 3rd line metastatic colorectal cancer.
Sonaro addresses the millions that go undiagnosed or misdiagnosed for stroke risk with Vaso3D, a device-agnostic, AI-powered software that converts 2D ultrasound into high-quality 3D vascular imaging transforming 2D ultrasound into AI-driven 3D assessments for fast, reliable stroke risk screening at the point of care.
QuantaPro enables oncologists to determine—early and in real time—whether chemotherapy will work, using a single drop of blood. Beginning with the ERCC1 chemo-resistance test, the company addresses a long-standing clinical blind spot in oncology while building a scalable, high-margin proteomic testing platform that will expand to other chronic diseases.
Sugarfina is an international luxury candy brand that blends high-quality confections with a fun, modern aesthetic. The principals have invested $21M of their own capital, demonstrating strong conviction and alignment with long-term value creation. Powered by a seasoned leadership and management team with a proven track record of building, scaling, and successfully exiting consumer brands and rollups, Sugarfina is built to win. The company is executing an omni-channel premium brand roll-up across premium gifting, confectionery, and beverage categories, with significant growth opportunities ahead, including actionable M&A targets.